Zum Anzeigen dieser Inhalte ist ein JoVE-Abonnement erforderlich. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.
Kapitel
- 00:04Titel
- 00:28Synthesis of 4-[5-(methylthio)-1,3,4-oxadiazol-2-yl]-aniline (1)
- 01:15Synthesis of Tert-butyl[18-({4-[5-(methylthio)-1,3,4-oxadiazol-2-yl]phenyl}amino)-15,18-dioxo-4,7,10-trioxa-14-azaoctadecyl] Carbamate (2)
- 03:00Synthesis of Tert-butyl[18-({4-[5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl]phenyl}amino)-15,18-dioxo-4,7,10-trioxa-14-azaoctadecyl] Carbamate (3)
- 03:55Synthesis of N1-(3-{2-[2-(3-aminopropoxy)ethoxy]-ethoxy}propyl)-N4-{4-[5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl] phenyl}Succinamide (PODS)
- 04:47Synthesis of PODS-DOTA and Bioconjugation of PODS-DOTA to Trastuzumab
- 06:05Results: Synthesis of PODS and PODS-DOTA and Conjugation to Trastuzumab
- 08:01Conclusion
Tags
Thiol-reactive ReagentsSite-specific BioconjugationImmunoconjugatesPODSMaleimide-thiol-based BioconjugationAminophenyl Oxadiazole ThiolDiisopropylethylamineIodomethaneBoc-protected Carboxylic AcidDichloromethaneEDCIAnilineHydrochloric AcidSodium CarbonateMagnesium SulfateEthyl AcetateCyclohexaneCarbamateM-chloroperbenzoic Acid
